טוען...
FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?
Patients with acute myeloid leukemia who harbor an FMS-like tyrosine kinase 3 (FLT3) mutation present several dilemmas for the clinician. The results of an FLT3 mutation test, which can be influenced by several variables, need to be interpreted according to the clinical setting and there is a need f...
שמור ב:
| הוצא לאור ב: | Hematology Am Soc Hematol Educ Program |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4714709/ https://ncbi.nlm.nih.gov/pubmed/24319184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/asheducation-2013.1.220 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|